← Eichor
Condition: Autologous Hematopoietic Stem Cell Transplantation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autologous Hematopoietic Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequenti
Phase 2 · 11 location(s) · SCRI Development Innovations, LLC · NCT06974786Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
EARLY_Phase 1 · 1 location(s) · Beijing Boren Hospital · NCT07626476A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06589089Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Partici
Phase 3 · 212 location(s) · European Myeloma Network B.V. · NCT05243797Eltrombopag for Peripheral Blood Stem Cell Harvest
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT05961410Autologous Demineralized Dentin Graft With or Without Melatonin for Immediate Implant Osseointegration
NA · 1 location(s) · Suez Canal University · NCT07610876Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With
Phase 1/Phase 2 · 10 location(s) · Anocca AB · NCT07145450Epidermal Skin Grafts to Improve Healing In Radiation Wounds
NA · 1 location(s) · Massachusetts General Hospital · NCT04560803A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
NA · 1 location(s) · Weill Medical College of Cornell University · NCT04891510A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmaco
Phase 1 · 2 location(s) · Vall d'Hebron Institute of Oncology · NCT07593820An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
NA · 1 location(s) · The First Affiliated Hospital of University of Science and T · NCT06503224Study of CD19 CAR-T Therapy for Refractory SLE
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07403097Autologous Transobturator Fascia Lata Sling in Treatment of Female Stress Urinary Incontinence
NA · 2 location(s) · Al-Azhar University · NCT05646745Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Phase 1 · 1 location(s) · Hackensack Meridian Health · NCT03909412a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage
Phase 2 · 2 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT02919644Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
Phase 2/Phase 3 · 1 location(s) · Genesis Athens Clinic · NCT03951194Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07233642Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07443020The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT06244264Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06682130Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 1 · 3 location(s) · SIRPant Immunotherapeutics, Inc. · NCT05967416Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
Phase 1/Phase 2 · 1 location(s) · Stephan Grupp MD PhD · NCT05480449Fertility Restoration With Autografting of Cryopreserved Immature Testicular Tissue
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT07542626Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Phase 2/Phase 3 · 1 location(s) · Genesis Athens Clinic · NCT05181748Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
Phase 1 · 1 location(s) · Daniel Bauer · NCT06647979A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T
Phase 1/Phase 2 · 13 location(s) · Cabaletta Bio · NCT04422912Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous A
Phase 2 · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT05857371
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.